The FDA approval for this therapy is for use in adult patients with a diagnosis of primary mediastinal B cell lymphoma, high grade B cell lymphoma (DLBCL) arising from follicular lymphoma. It is for patients who have either not responded to, or relapsed after, two or more other types of cancer therapy.
Refer a Patient
To refer a patient for CAR-T therapy at Baylor Dallas, please call 214.820.3535 to speak with a patient navigation specialist.
A CAR-T clinical trial at Baylor Charles A. Sammons Cancer Center may be offered for other types of cancer, and can be found by calling a patient navigation specialist or searching our clinical trial database.
Find a CAR-T Research Trial